Core Viewpoint - Lens Technology (300433.SZ) experienced a stock price decline of 4.11%, closing at 35.44 yuan on February 5 [1]. Group 1: Stock Performance - On January 12, Lens Technology's stock reached an intraday high of 43.44 yuan, marking the highest point of the year [2]. - The recent decline in stock price indicates a significant drop from its peak earlier in the month [1][2]. Group 2: Analyst Insights - Xu Liang, an analyst from Aijian Securities, maintained a "Buy" rating and profit forecast for Lens Technology in a report published on January 12, highlighting the company's advancements in cutting-edge applications ahead of CES 2026 [2].

Core Viewpoint - Hunan Province has announced a total of 430 key construction and preliminary work projects for 2026, with a total investment of 2 trillion yuan, focusing on infrastructure, ecological protection, social welfare, and industrial development [1] Group 1: Key Construction Projects - The list includes 389 key construction projects and 41 key preliminary work projects [1] - The infrastructure projects consist of 152 projects, including major initiatives in energy, urban infrastructure, and transportation [1] - Significant infrastructure projects include the "source-network-load-storage" integration project, "four-network integration" computing power project, and urban infrastructure renovation [1] Group 2: Transportation Development - The plan includes the acceleration of six high-speed rail lines and the expansion of 17 expressways [1] - Major water conservancy projects such as the Meishan Irrigation District and Jintangchong Reservoir are also part of the construction agenda [1] Group 3: Industrial Development - The focus is on a "4×4" modern industrial system, enhancing 13 key industrial chains and "5+5" advanced manufacturing clusters [1] - Key industrial projects include the development of next-generation lithium batteries, 3D glass production, and new energy drive systems [1]

Group 1 - Hongfuhuan Technology Co., Ltd. signed a tripartite cooperation framework agreement with Guangdong Quanjing Intelligent Technology Co., Ltd. and Jiangxi Xiexun Intelligent Equipment Co., Ltd. to enhance collaboration in AI servers and robotics [1] - The sales contract with Guangdong Quanjing amounts to RMB 480 million, accounting for approximately 59.68% of the company's audited main business revenue for 2024 [1] - The collaboration aims to explore commercial opportunities in AI server hardware supply, software adaptation, system integration, and customized development [2] Group 2 - Guangdong Quanjing focuses on the research and manufacturing of fork robots and possesses core technologies in key components, navigation, and intelligent logistics scheduling [2] - Jiangxi Xiexun, a wholly-owned subsidiary of Luxshare Precision, engages in ODM/JDM/OEM business for robotic products and smart warehousing solutions [2] - The signing of the contract is seen as a significant milestone for Hongfuhuan's transition from traditional consumer electronics to the AI hardware supply chain, expected to enhance the company's operating performance [2]

1 / 1 蓝思科技股份有限公司（以下简称"公司"）于 2026 年 1 月 12 日召开第五 届董事会第十次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资 金的议案》，同意公司使用不超过人民币 9 亿元的暂时闲置募集资金临时补充流 动资金，使用期限自本次董事会审议通过之日起不超过 12 个月，即本次补充流 动资金到期日为 2027 年 1 月 11 日。具体内容详见公司于 2026 年 1 月 13 日在巨 潮资讯网（http://www.cninfo.com.cn）等符合中国证监会规定条件的媒体上发布 的《关于使用部分闲置募集资金暂时补充流动资金的公告》。 近日，公司提前归还了 5,000 万元临时补充流动资金的募集资金至募集资金 专项账户，并就上述归还事项通知了公司保荐机构和保荐代表人。剩余 8.5 亿元 临时补充流动资金的暂时闲置募集资金将在到期前足额归还，届时公司将及时履 行信息披露义务。 特此公告。 蓝思科技股份有限公司董事会 二○二六年二月四日 证券代码：300433 证券简称：蓝思科技 公告编号：临 2026-011 蓝思科技股份有限公司 关于提前归还部分临时补充流动资金的闲置募集资 ...

香港 交 易及結算所有限公司及香港聯合 交 易所有限公司對本公告 之 內容概 不 負責 ， 對其準確性或完整性 亦不 發表 任 何聲明 ，並 明確表示概 不 就因本公告全部或 任 何部 份 內容而產 生或因倚 賴 該等內容而引致之任何損 失承 擔 任 何 責任 。 Lens Technology Co., Ltd. 藍 思 科 技 股 份 有 限 公 司 （ 於 中 華人民共和國註冊成立的股份有限公司 ） （股份代號：6613） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第 13.10B 條刊發。 承董事會命 藍思科技股份有限公司 董事長 周群飛 香港，2026 年 2 月 4 日 於本公告日期 ， 本公司董 事 會成員包括 執 行董 事 周群飛女士 、 鄭俊龍先 生 及饒橋兵 先 生； 及獨立非 執 行董 事 萬煒女士 、 劉岳 先生 、 田宏先生及汤湘希先生 。 证券代码：300433 证券简称：蓝思科技 公告编号：临 2026-011 蓝思科技股份有限公司 关于提前归还部分临时补充流动资金的闲置募集资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误 ...

Core Viewpoint - The company is establishing a new subsidiary, Jietai Intelligent Manufacturing, in collaboration with two investment partners, focusing on high-end intelligent equipment and new materials for consumer electronics, which is a strategic move to enhance its transformation in the consumer electronics sector and capture opportunities in the space photovoltaic market [1][4] Group 1: Company Strategy - The new subsidiary, Jietai Intelligent Manufacturing, has a registered capital of 50 million yuan, with the company holding a 51% stake, ensuring absolute control [1] - The business scope of the new company includes research, production, and sales of high-end intelligent equipment, superhard materials, and electronic new materials, which aligns with the core needs of the consumer electronics industry [1][2] - The establishment of Jietai Intelligent Manufacturing represents a further deepening of the company's "equipment + consumables" integrated strategy, following its previous collaboration with global consumer electronics glass manufacturers [2] Group 2: Market Opportunities - The company is leveraging its core technology in diamond wire to enter the space photovoltaic sector, which is expected to grow rapidly, with silicon-based components being a key material [3] - The company's diamond wire technology offers a competitive advantage in precision and cost control, which is crucial for the high standards required in space photovoltaic production [3] - The global photovoltaic industry is evolving towards efficiency and diversification, with space photovoltaic presenting significant growth potential, positioning the company as a key supplier in this emerging market [3][4] Group 3: Financial Performance - In 2025, the company faced pressure from the photovoltaic industry cycle, but it has shown significant operational improvement in the fourth quarter, indicating the gradual contribution of its new consumer electronics business [4] - The dual-track strategy of focusing on consumer electronics and space photovoltaic is seen as a clear strategic logic, with the potential to enhance the company's resilience against industry cycles [4]

Market Overview - The US stock market experienced a decline, with the Chinese concept index dropping by 0.94%. The Hang Seng Index fell by 110.27 points, a decrease of 0.41%, closing at 26,724.50 points, while the Hang Seng Tech Index dropped by 120.19 points, down 2.20%, reaching a new low since mid-July 2025 [1] - Technology stocks, particularly those considered riskier, continued to decline, with Tencent falling nearly 4% after restrictions on its "Yuanbao Red Packet" link by WeChat. Other major players like Baidu, Meituan, and Xiaomi also saw declines of over 2%, while Bilibili dropped nearly 5% [1] - Chip stocks faced significant losses, with Shanghai Fudan down nearly 9%, Huahong Semiconductor down over 5%, and SMIC down nearly 3% [1] - The coal sector showed strength, with Feishang No Smoke Coal rising over 33%. Real estate stocks also performed well, with Sunac China up over 7% and China Resources Land up nearly 4% [1] Corporate Developments - In the technology sector, InnoCare successfully completed a significant design integration for AI hardware with Google, establishing a solid foundation in the AI hardware market [1] - Enoch Intelligent received a milestone payment of HKD 39 million from Menarini, marking a significant step in its pharmaceutical technology research [1] - Capital investment firm Shumeng Capital signed a contract worth USD 3 million with a Macau distributor, expanding its business footprint [1] Pharmaceutical Industry Highlights - Youzhiyou Biotech's M701 received FDA IND approval for a novel therapy targeting malignant pleural effusion, marking a new phase in international clinical development [2] - Xiansheng Pharmaceutical received a milestone payment of USD 40 million from AbbVie for the overseas licensing option agreement for SIM0500, highlighting its competitiveness in the international pharmaceutical market [2] - Kangfang Biotech granted exclusive commercialization rights for Yixinning® to Jichuan Pharmaceutical, resulting in significant licensing fees and milestone payments [2] - Federal Pharmaceuticals' UBT251 injection received implied clinical trial approval for a new indication, providing new treatment options for patients [2] Food Industry Performance - Nissin Foods reported strong performance in its China business segment, with revenue reaching JPY 54.948 billion, a year-on-year increase of 2.7%, and core operating profit of JPY 5.859 billion, up 9.3% [2] Capital Market Insights - Guotai Junan International noted a market shift from "liquidity-driven" to "profit-driven" dynamics, suggesting a focus on fundamental analysis rather than speculative trading [4] - CITIC Securities observed significant adjustments in Hong Kong stock earnings expectations, predicting a continuation of the spring market rally with large-cap stocks outperforming [4] - Huatai Securities indicated that the current market sentiment has shifted to optimism, suggesting a focus on companies with earnings certainty and potential for growth in technology and cyclical sectors [5] - Guoyuan International highlighted that Hong Kong stocks may continue to outperform US stocks due to favorable conditions for non-US assets and the potential recovery of domestic demand [5]

Summary of Key Points Core Viewpoint - Lens Technology (300433.SZ) announced a share buyback program, successfully repurchasing a total of 7,409,607 shares, which represents 0.15% of the company's current A-share total capital [1] Group 1: Buyback Details - The buyback was conducted through a dedicated repurchase securities account using a centralized bidding method [1] - The highest transaction price during the buyback was 30.24 CNY per share, while the lowest was 22.50 CNY per share [1] - The total amount paid for the repurchased shares was 214,823,659.63 CNY, excluding transaction fees [1]

Core Viewpoint - Lens Technology experienced a stock price decline of 2.01% on February 4, with a current price of 36.61 CNY per share and a market capitalization of 193.46 billion CNY [1] Group 1: Stock Performance - Year-to-date, Lens Technology's stock price has increased by 20.94%, but it has decreased by 3.45% over the last five trading days [1] - Over the past 20 days, the stock price has risen by 7.64%, and it has increased by 22.65% over the last 60 days [1] Group 2: Financial Data - For the period from January to September 2025, Lens Technology reported a revenue of 53.663 billion CNY, representing a year-on-year growth of 16.08% [2] - The net profit attributable to shareholders for the same period was 2.843 billion CNY, showing a year-on-year increase of 19.91% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Lens Technology was 159,900, an increase of 8.17% from the previous period [2] - The average number of circulating shares per shareholder decreased by 7.52% to 31,070 shares [2] Group 4: Dividends and Institutional Holdings - Lens Technology has distributed a total of 9.993 billion CNY in dividends since its A-share listing, with 4.980 billion CNY distributed in the last three years [3] - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited and E Fund's various ETFs, with notable changes in their holdings [3]

Group 1 - The Hong Kong stock market for the smartphone supply chain has seen a collective decline, with notable drops including High伟电子 down over 6% and 蓝思科技 down nearly 6% [1] - By December 2025, China's smartphone sales are projected to reach approximately 21 million units, representing a year-on-year decline of about 20% [1] - Major smartphone brands such as 华为, OPPO, 荣耀, vivo, and 苹果 hold market shares of approximately 20%, 17%, 14%, 14%, and 13% respectively [1] Group 2 - Goldman Sachs has revised its global smartphone shipment forecasts for 2026/27 down by 6% and 5% to 1.2 billion units each year, indicating a year-on-year change of -6% and +2% [1] - Counterpoint Research suggests that the smartphone market is unlikely to recover before 2027, with normalization expected in the second half of 2027 or early 2028 [1] - The smartphone industry is expected to seek a balance between cost, performance, and innovation in response to ongoing challenges and rising costs due to memory price increases and technological iterations [1]